Your browser doesn't support javascript.
loading
The Combination of Anlotinib and Gemcitabine/Docetaxel in Patients with Metastatic Osteosarcoma Who Have Failed Standard Chemotherapy.
Wang, Tian; Lin, Feng; Huang, Yujing; Qian, Guowei; Yu, Wenxi; Hu, Haiyan; Ji, Tong; Tang, Lina; Yao, Yang.
Afiliação
  • Wang T; The Eighth People's Hospital of Shanghai, Shanghai, People's Republic of China.
  • Lin F; Shanghai Sixth People's Hospital, Shanghai Jiaotong University, Shanghai, People's Republic of China.
  • Huang Y; Shanghai Sixth People's Hospital, Shanghai Jiaotong University, Shanghai, People's Republic of China.
  • Qian G; Shanghai Sixth People's Hospital, Shanghai Jiaotong University, Shanghai, People's Republic of China.
  • Yu W; Shanghai Sixth People's Hospital, Shanghai Jiaotong University, Shanghai, People's Republic of China.
  • Hu H; Shanghai Sixth People's Hospital, Shanghai Jiaotong University, Shanghai, People's Republic of China.
  • Ji T; Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, People's Republic of China.
  • Tang L; Shanghai Sixth People's Hospital, Shanghai Jiaotong University, Shanghai, People's Republic of China.
  • Yao Y; Shanghai Sixth People's Hospital, Shanghai Jiaotong University, Shanghai, People's Republic of China.
Cancer Manag Res ; 14: 2945-2952, 2022.
Article em En | MEDLINE | ID: mdl-36217441
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article